HK1033275A1 - Remedy for hepatopathy. - Google Patents
Remedy for hepatopathy.Info
- Publication number
- HK1033275A1 HK1033275A1 HK01103997A HK01103997A HK1033275A1 HK 1033275 A1 HK1033275 A1 HK 1033275A1 HK 01103997 A HK01103997 A HK 01103997A HK 01103997 A HK01103997 A HK 01103997A HK 1033275 A1 HK1033275 A1 HK 1033275A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- hepatic
- caused
- active ingredient
- compositions
- acids
- Prior art date
Links
- 208000019423 liver disease Diseases 0.000 title abstract 4
- 239000004480 active ingredient Substances 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 206010000087 Abdominal pain upper Diseases 0.000 abstract 1
- 206010003445 Ascites Diseases 0.000 abstract 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 abstract 1
- 208000002151 Pleural effusion Diseases 0.000 abstract 1
- 206010037660 Pyrexia Diseases 0.000 abstract 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 abstract 1
- 206010047700 Vomiting Diseases 0.000 abstract 1
- 230000005856 abnormality Effects 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 150000007513 acids Chemical class 0.000 abstract 1
- 150000001413 amino acids Chemical class 0.000 abstract 1
- 230000004596 appetite loss Effects 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 206010016256 fatigue Diseases 0.000 abstract 1
- 235000013305 food Nutrition 0.000 abstract 1
- 208000007386 hepatic encephalopathy Diseases 0.000 abstract 1
- 235000021266 loss of appetite Nutrition 0.000 abstract 1
- 208000019017 loss of appetite Diseases 0.000 abstract 1
- 238000001050 pharmacotherapy Methods 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- 238000011084 recovery Methods 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 abstract 1
- 239000004474 valine Substances 0.000 abstract 1
- 230000008673 vomiting Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Mycology (AREA)
- Polymers & Plastics (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP26579397 | 1997-09-30 | ||
| PCT/JP1998/004405 WO1999016433A1 (fr) | 1997-09-30 | 1998-09-30 | Medicament pour l'hepatopathie |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1033275A1 true HK1033275A1 (en) | 2001-08-24 |
Family
ID=17422126
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK01103997A HK1033275A1 (en) | 1997-09-30 | 2001-06-11 | Remedy for hepatopathy. |
Country Status (11)
| Country | Link |
|---|---|
| EP (2) | EP1025844B1 (xx) |
| KR (2) | KR20010030820A (xx) |
| CN (1) | CN1149988C (xx) |
| AT (1) | ATE336241T1 (xx) |
| AU (1) | AU9280298A (xx) |
| CA (1) | CA2305206A1 (xx) |
| DE (1) | DE69835609T2 (xx) |
| HK (1) | HK1033275A1 (xx) |
| TW (1) | TW473387B (xx) |
| WO (1) | WO1999016433A1 (xx) |
| ZA (1) | ZA988924B (xx) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU6726200A (en) * | 1999-08-23 | 2001-03-19 | Chugai Seiyaku Kabushiki Kaisha | Remedies for liver regeneration of transplanted liver |
| TW200626080A (en) | 2000-10-13 | 2006-08-01 | Chugai Pharmaceutical Co Ltd | Food compositions comprising valine for improving lipid metabolism |
| WO2003063853A1 (fr) * | 2002-01-31 | 2003-08-07 | Chugai Seiyaku Kabushiki Kaisha | Compositions de reduction de la graisse mesenterique |
| CN102458417B (zh) * | 2009-06-24 | 2015-02-25 | 味之素株式会社 | 核酸类似物的活性增强剂 |
| JOP20190146A1 (ar) | 2016-12-19 | 2019-06-18 | Axcella Health Inc | تركيبات حمض أميني وطرق لمعالجة أمراض الكبد |
| JP7266581B2 (ja) | 2017-08-14 | 2023-04-28 | アクセラ・ヘルス・インコーポレイテッド | 肝疾患の治療のためのアミノ酸組成物 |
| US10596136B2 (en) | 2018-06-20 | 2020-03-24 | Axcella Health Inc. | Compositions and methods for the treatment of fat infiltration in muscle |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5668374A (en) * | 1979-11-08 | 1981-06-09 | Jun Sawada | Food composition for hepatic insufficiency |
| JPS61186320A (ja) * | 1985-02-12 | 1986-08-20 | Morishita Seiyaku Kk | アミノ酸製剤 |
| JP2618653B2 (ja) * | 1987-09-22 | 1997-06-11 | ルセル森下株式会社 | 肝性脳症患者用アミノ酸製剤 |
| EP0605742A4 (en) * | 1992-06-26 | 1996-01-03 | Nonna Dmitrievna Kislyakova | Agent with adaptogenic activity. |
| ATE289809T1 (de) * | 1994-06-23 | 2005-03-15 | Chugai Pharmaceutical Co Ltd | Verwendung von valin zur herstellung eines medikaments zur leberregeneration |
-
1998
- 1998-09-24 TW TW087115898A patent/TW473387B/zh not_active IP Right Cessation
- 1998-09-30 WO PCT/JP1998/004405 patent/WO1999016433A1/ja active IP Right Grant
- 1998-09-30 DE DE69835609T patent/DE69835609T2/de not_active Expired - Fee Related
- 1998-09-30 KR KR1020007003441A patent/KR20010030820A/ko active Search and Examination
- 1998-09-30 KR KR1020057002626A patent/KR100562739B1/ko not_active IP Right Cessation
- 1998-09-30 CN CNB988107287A patent/CN1149988C/zh not_active Expired - Fee Related
- 1998-09-30 AU AU92802/98A patent/AU9280298A/en not_active Abandoned
- 1998-09-30 ZA ZA988924A patent/ZA988924B/xx unknown
- 1998-09-30 EP EP98945536A patent/EP1025844B1/en not_active Expired - Lifetime
- 1998-09-30 EP EP06016819A patent/EP1714649A3/en not_active Withdrawn
- 1998-09-30 CA CA002305206A patent/CA2305206A1/en not_active Abandoned
- 1998-09-30 AT AT98945536T patent/ATE336241T1/de not_active IP Right Cessation
-
2001
- 2001-06-11 HK HK01103997A patent/HK1033275A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| DE69835609T2 (de) | 2007-08-09 |
| CN1149988C (zh) | 2004-05-19 |
| KR100562739B1 (ko) | 2006-03-20 |
| EP1025844A1 (en) | 2000-08-09 |
| EP1714649A2 (en) | 2006-10-25 |
| TW473387B (en) | 2002-01-21 |
| WO1999016433A1 (fr) | 1999-04-08 |
| DE69835609D1 (de) | 2006-09-28 |
| EP1025844B1 (en) | 2006-08-16 |
| EP1714649A3 (en) | 2007-09-05 |
| CN1278168A (zh) | 2000-12-27 |
| KR20010030820A (ko) | 2001-04-16 |
| EP1025844A4 (en) | 2002-10-02 |
| ATE336241T1 (de) | 2006-09-15 |
| KR20050054921A (ko) | 2005-06-10 |
| CA2305206A1 (en) | 1999-04-08 |
| AU9280298A (en) | 1999-04-23 |
| ZA988924B (en) | 1999-03-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2146633A1 (en) | Concentrated bioavailable calcium source | |
| FI844364A0 (fi) | Produkt, som kan foeraendras. | |
| JP2005336211A (ja) | 過敏症の歯の治療 | |
| ATE296545T1 (de) | Zusatz für die wiederherstellung des wachstumhormonspiegels | |
| HK1033275A1 (en) | Remedy for hepatopathy. | |
| EP0402755A3 (de) | L-Carnitin-Magnesium-Zitrat | |
| FR2705673B1 (fr) | Compositions comportant des dérivés d'acides aminés, leurs procédés de préparation et leurs utilisations. | |
| CA2332915A1 (en) | Compositions comprising gaba analogs and caffeine | |
| HAGIHIRA et al. | INTESTINAL ABSORPTION OF AMINO ACIDS III. INTERFERENCE BETWEEN AMINO ACIDS DURING INTESTINAL ABSORPTION | |
| PL352578A1 (en) | Dietary supplement for containing alknoyl derivative of carnitin and ribose for ehnancing energetic metabolism of muscles | |
| PT948328E (pt) | Composicoes a base de aminoacidos | |
| CA2039855A1 (en) | Difluoroglutamic acid conjugates with folates and anti-folates for the treatment of neoplastic diseases | |
| WO2003049687A3 (en) | Medicinal compositions & therapeutic methods | |
| US5378722A (en) | Nutritional compositions for management of nitrogen metabolism | |
| IL71650A (en) | Pharmaceutical compositions comprising a combination of ypsilon-vinyl gaba together with a glycine derivative | |
| AU8530891A (en) | 5-aminosalicylic acid derivatives for the therapy of chronic inflammatory bowel diseases | |
| IL112388A0 (en) | Pharmaceutical compositions | |
| NZ228208A (en) | Eglin compounds (hurudin) and protease inhibitor pharmaceutical compositions | |
| ES2168508T3 (es) | Empleo de treonina para el tratamiento de fenil-cetonuria. | |
| EP0624368A3 (en) | Use of a composition to stimulate glutathione synthesis for the manufacture of a medicament for the treatment of AID. | |
| EP1306366A3 (en) | New dibenzosuberone derivatives | |
| Andersen et al. | Diet composition determines the bioavailability of cadmium for intestinal uptake | |
| CA2203228A1 (en) | Gluten lactose blends | |
| Andersen et al. | Effects of DDC and related compounds on cadmium toxicokinetics | |
| PL327471A1 (en) | Aminoguanidines for trweating niddm |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20080930 |